Yangjisa Co., Ltd. (KOSDAQ:030960)
South Korea · Delayed Price · Currency is KRW 7,290.00
+70.00 (0.97%)
At close: Mar 18, 2026
Yangjisa Market Cap
Yangjisa has a market cap or net worth of 100.14 billion as of March 18, 2026. Its market cap has decreased by -25.38% in one year.
Market Cap
100.14B
Enterprise Value
n/a
Revenue
45.16B
Ranking
n/a
PE Ratio
577.79
Stock Price
7,290.00
Market Cap Chart
Since September 14, 2000, Yangjisa's market cap has increased from 18.49B to 100.14B, an increase of 441.66%. That is a compound annual growth rate of 6.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 100.14B | -6.42% |
| Dec 30, 2025 | 107.00B | -21.94% |
| Dec 30, 2024 | 137.09B | -23.11% |
| Dec 28, 2023 | 178.29B | -59.31% |
| Dec 29, 2022 | 438.18B | 242.64% |
| Dec 30, 2021 | 127.88B | -3.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daejung Chemicals & Metals | 98.15B |
| Remed | 98.13B |
| NEXUS | 97.90B |
| ALT Co., Ltd | 97.89B |
| Amicogen | 97.65B |
| HBL Corporation | 97.43B |
| Sam-A Pharm. | 97.41B |
| HUMAN TECHNOLOGY | 97.28B |